(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase

Diabetes and Vascular Disease Research

Volumn 13, Issue 3, 2016, Pages 201-210

  Ramírez Sánchez, Israel ^a,b   Rodríguez, Alonso ^b   Moreno Ulloa, Aldo ^a,b   Ceballos, Guillermo ^a   Villarreal, Francisco ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

( ) Epicatechin; cardiomyocytes; diabetes; endothelial cells; endothelial nitric oxide synthase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN; GLUCOSE; MITOCHONDRIAL PROTEIN; NITRIC OXIDE; SIRTUIN 1; TRANSCRIPTION FACTOR; CATECHIN; ENZYME INHIBITOR; NOS3 PROTEIN, HUMAN; NOS3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MITOCHONDRIAL BIOGENESIS; MITOCHONDRION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HEART MITOCHONDRION; METABOLISM; ORGANELLE BIOGENESIS; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CATECHIN; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ORGANELLE BIOGENESIS; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84964323832     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164115620982     Document Type: Article

References (30)

1. Vita JA, Keaney JF Jr., Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 106: 640-642.
2. Hsieh PC, Davis ME, Lisowski LK, et al. Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol 2006; 68: 51-66.
3. Nisoli E, Carruba MO,. Nitric oxide and mitochondrial biogenesis. J Cell Sci 2006; 119: 2855-2862.
4. Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003; 299: 896-899.
5. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466-8471.
6. Akbari CM, Saouaf R, Barnhill DF, et al. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 1998; 28: 687-694.
7. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.
8. Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996; 94: 1276-1282.
9. Van de Ree MA, Huisman MV, de Man FH, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res 2001; 52: 299-305.
10. Du XL, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001; 108: 1341-1348.
11. Musicki B, Kramer MF, Becker RE, et al. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2005; 102: 11870-11875.
12. Ramirez-Sanchez I, Maya L, Ceballos G, et al. (-)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension 2010; 55: 1398-1405.
13. Ramirez-Sanchez I, Maya L, Ceballos G, et al. (-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cells. Am J Physiol Cell Physiol 2011; 300: C880-C887.
14. Ramirez-Sanchez I, Aguilar H, Ceballos G, et al. (-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT. Mol Cell Biochem 2012; 370: 141-150.
15. Moreno-Ulloa A, Cid A, Rubio-Gayosso I, et al. Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. Bioorg Med Chem Lett 2013; 23: 4441-4446.
16. Nogueira L, Ramirez-Sanchez I, Perkins GA, et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol 2011; 589: 4615-4631.
17. Taub PR, Ramirez-Sanchez I, Ciaraldi TP, et al. Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa. Clin Transl Sci 2012; 5: 43-47.
18. Gutierrez-Salmean G, Ortiz-Vilchis P, Vacaseydel CM, et al. Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors. Eur J Pharmacol 2014; 728: 24-30.
19. Winzell MS, Ahren B,. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004; 53 (Suppl. 3): S215-S219.
20. Massion PB, Feron O, Dessy C, et al. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 2003; 93: 388-398.
21. Brossette T, Hundsdorfer C, Kroncke KD, et al. Direct evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cells. Eur J Nutr 2011; 50: 595-599.
22. Richelle M, Tavazzi I, Enslen M, et al. Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr 1999; 53: 22-26.
23. Csiszar A, Labinskyy N, Pinto JT, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2009; 297: H13-H20.
24. Kirpichnikov D, Sowers JR,. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab 2001; 12: 225-230.
25. Valle I, Alvarez-Barrientos A, Arza E, et al. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 2005; 66: 562-573.
26. Calvert JW, Lefer DJ,. Myocardial protection by nitrite. Cardiovasc Res 2009; 83: 195-203.
27. Flaherty MP, Brown M, Grupp IL, et al. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 2007; 7: 165-177.
28. Calvert JW, Gundewar S, Jha S, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 2008; 57: 696-705.
29. Yasuda S, Kobayashi H, Iwasa M, et al. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction. Am J Physiol Heart Circ Physiol 2009; 296: H1558-H1565.
30. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-1122.